Overexpression of cyclooxygenase-2 is associated with a poor prognosis in patients with squamous cell carcinoma of the uterine cervix treated with radiation and concurrent chemotherapy

Cancer

Volumn 95, Issue 3, 2002, Pages 531-539

  Yong, Bae Kim ^a   Gwi, Eon Kim ^a   Nam, Hoon Cho ^b   Hong, Ryull Pyo ^a   Su, Jung Shim ^a   Sei, Kyung Chang ^a   Hee, Chul Park ^a   Chang, Ok Suh ^a   Tchan, Kyu Park ^b   Byung, Soo Kim ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Cyclooxygenase 2; Prognostic factor; Radiotherapy with concurrent chemotherapy; Squamous cell carcinoma; Uterine cervical carcinoma

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CYCLOOXYGENASE 2; FLUOROURACIL;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; FEMALE; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SQUAMOUS CELL CARCINOMA; TREATMENT FAILURE; UTERINE CERVIX CARCINOMA;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; CYCLOOXYGENASE 2; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; MEMBRANE PROTEINS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 0036682406     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.10684     Document Type: Article

References (37)

1. Cancer of the cervix, vagina and vulva
2. Disease control of uterine cervical cancer: Relationship to tumor oxygen tension, vascular density, cell density, and frequency of mitosis and apoptosis measured before treatment and during radiotherapy
3. Cyclooxygenase-2 expression in human glioma: Prognostic significance and molecular correlations
4. Expression of cyclooxygenase-2 in human breast carcinoma: Relevance to tumor angiogenesis and expression of estrogen receptor
5. Cyclooxygenase-2 overexpression is a marker of poor prognosis in Stage I non-small cell lung cancer
6. Up-regulation of cyclooxygenase-2 in squamous carcinogenesis of the esophagus
7. Increased expression of cyclooxygenase-2 protein in human gastric cancer
8. The relationship between cyclooxygenase-2 expression and colorectal cancer
9. Cyclooxygenase-2 overexpression correlates with tumor recurrence, specially haematogenous metastasis, of colorectal cancer
10. Cyclooxygenase-2 expression correlates with tumor neovascularization and prognosis in human cororectal carcinoma patients
11. High cyclooxygenase-2 expression in Stage IB cervical cancer with lymph node metastasis or parametrial invasion
12. Elevated cyclooxygenase-2 expression correlates with diminished survival in carcinoma of the cervix treated with radiotherapy
13. Why there are two cyclooxygenase isozymes
14. Cyclooxygenases: Structural, cellular, and molecular biology
15. The role of cyclooxygenases in inflammation, cancer, and development
16. Expression of cyclooxygenase-2 in human lung carcinoma
17. COX-2 is expressed in human pulmonary, colonic, and mammary tumors
18. Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: Growth inhibition by nonsteroidal anti-inflammatory drugs
19. Up-regulation of cyclooxygenase-2 gene expression in human colorectal adenomas and adenocarcinomas
20. Host cyclooxygenase-2 modulated carcinoma growth
21. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2
22. Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: Independence from COX-2 protein expression
23. Cyclooxtgenase-2 expression in human colon cancer cells increases metastatic potential
24. Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors
25. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer
26. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer
27. Concurrent chemotherapy and radiotherapy in invasive cervical carcinoma patients with high risk factors
28. Subcellular localization of prostaglandin endoperoxide H synthases-1 and -2 by immunoelectron microscopy
29. Cyclooxygenase-2: A pharmacological target for the prevention of cancer
30. Expression of prostaglandin G/H synthase type 1, but not type 2, in human ovarian adenocarcinomas
31. Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer
32. 2, and matrix metalloproteinases
33. Blockade of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation
34. Non-small cell lung cancer cyclooxygenase activity and proliferation are inhibited by non-steroidal anti-inflammatory drugs
35. Enhancement of chemotherapeutic drug toxicity to human tumor cells in vitro by a subset of non-steroidal anti-inflammatory drugs (NSAIDs)
36. Enhancement of tumor response to γ-radiation by an inhibitor of cyclooxygenase-2 enzyme
37. Preferential enhancement of tumor radioresponse by a cyclooxygenase-2 inhibitor